An observational study in Respiratory Tract Infections, sponsored by Cepheid. Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2026-03-24.
Sponsored by Cepheid · Observational
A multi-site observational all-comers study that will be conducted at geographically diverse sites within the United States
Prospectively collected Nasopharyngeal swab specimens will be collected from consented individuals with signs and symptoms of respiratory tract infection at a single timepoint
1,031 studies on the registry are indexed under Respiratory Tract Infections; 144 are open to participants now.
This study's enrollment of 3,200 is above the median of 300 across 295 observational studies indexed under Respiratory Tract Infections.
Browse Respiratory Tract Infections studies →Cepheid is the lead sponsor of 10 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Specimens collected from individuals with signs and symptoms of respiratory tract infection
Exclusion Criteria:
Nasopharyngeal Swab specimens from individuals with signs and symptoms of respiratory tract infection
Diagnostic Test: Xpert ERP
Detection and Identification of DNA and RNA from multiple bacteria and viruses from nasopharyngeal swabs
Xpert test compared to comparator(s) tests
Evaluating the clinical performance (PPA and NPA) of Xpert ERP relative to comparator(s)
Time frame: Clinical Performance assessed on specimens collected at Baseline
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Cepheid